Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.

Abstract

Increasing azithromycin treatment failure in sexually transmitted Mycoplasma genitalium infection, is linked to macrolide resistance and second-line treatment relies on the fluoroquinolone, moxifloxacin. We recently detected fluoroquinolone and macrolide resistance-associated mutations in 15% and 43%, respectively, of 143 initial M. genitalium PCR-positive… (More)
DOI: 10.1177/0956462413502008

Topics

Cite this paper

@article{Couldwell2013FailureOM, title={Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.}, author={Deborah L. Couldwell and Kaitlin A. Tagg and Neisha J Jeoffreys and Gwendolyn L. Gilbert}, journal={International journal of STD & AIDS}, year={2013}, volume={24 10}, pages={822-8} }